Search Results - "Witte, Klaus K A"

Prognostic Significance of Incidental Nonsustained Ventricular Tachycardia Detected on Pacemaker Interrogation by Jamil, Haqeel A., Mohammed, Sajeel A., Gierula, John, Paton, Maria F., Lowry, Judith E., Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.A.

“…Symptomatic sustained ventricular tachycardia is a life threatening arrhythmia requiring prompt treatment. However, the risk associated with asymptomatic…”
Get full text

Anemia, Renal Dysfunction, and Their Interaction in Patients With Chronic Heart Failure by de Silva, Ramesh, Rigby, Alan S., Witte, Klaus K.A., Nikitin, Nikolay P., Tin, Lwin, Goode, Kevin, Bhandari, Sunil, Clark, Andrew L., Cleland, John G.F.

“…Anemia and renal dysfunction (RD) are frequent complications seen in chronic heart failure (HF). However, the prevalence and interaction of these…”
Get full text

Epidemiology, Associated Factors, and Prognostic Outcomes of Renal Artery Stenosis in Chronic Heart Failure Assessed by Magnetic Resonance Angiography by de Silva, Ramesh, MRCP, Loh, Huan, MRCP, Rigby, Alan S., CStat, Nikitin, Nikolay P., DSc, Witte, Klaus K.A., MD, Goode, Kevin, PhD, Bhandari, Sunil, PhD, Nicholson, Anthony, MD, Clark, Andrew L., MD, Cleland, John G.F., MD

“…Our aim was to determine the prevalence, morbidity, and mortality associated with the presence of significant renal artery stenosis (RAS) in patients with…”
Get full text

Are hematinic deficiencies the cause of anemia in chronic heart failure? by Witte, Klaus K.A, Desilva, Ramesh, Chattopadhyay, Sudipta, Ghosh, Justin, Cleland, John G.F, Clark, Andrew L

“…Anemia in chronic heart failure (CHF) is common, varying in prevalence between 14.4% and 55%, and is more frequent in patients with more severe heart failure…”
Get full text

Fibrinogen synthesis is increased in cachectic patients with chronic heart failure by Witte, Klaus K.A, Ford, Sarah J, Preston, Tom, Parker, John D, Clark, Andrew L

“…Abstract Introduction Cachexia is common in chronic heart failure (CHF) and may be due to a combination of reduced appetite, and increased metabolic rate due…”
Get full text

Carvedilol in the treatment of elderly patients with chronic heart failure by Witte, Klaus K A, Clark, Andrew L

“…Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and…”
Get full text

The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure by Witte, Klaus K.A., Nikitin, Nikolay P., Parker, Anita C., von Haehling, Stephan, Volk, Hans-Dieter, Anker, Stefan D., Clark, Andrew L., Cleland, John G.F.

“…Aims Chronic heart failure (CHF) is a common and leading cause of death in industrialized countries. The potential benefits of micronutrient supplementation in…”
Get full text

Cardiac resynchronisation therapy for chronic heart failure: predicting and measuring 'response' by Witte, Klaus K A

Get more information

Response to (resynchronization) therapy in chronic heart failure: time for a different approach by Gierula, John, Witte, Klaus K. A.

Get full text

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis by de Silva, Ramesh, Nikitin, Nikolay P., Witte, Klaus K.A., Rigby, Alan S., Goode, Kevin, Bhandari, Sunil, Clark, Andrew L., Cleland, John G.F.

“…Aims To determine the prevalence and incidence of renal dysfunction (RD) in patients with chronic heart failure (CHF), to identify contributory factors and…”
Get full text

Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure by Cubbon, Richard M., Thomas, Ceri Haf, Drozd, Michael, Gierula, John, Jamil, Haqeel A., Byrom, Rowenna, Barth, Julian H., Kearney, Mark T., Witte, Klaus K. A.

“…Background Serum calcium (Ca) and inorganic phosphate (Pi) concentrations and calcium-phosphate product (CPP) levels are positively associated with worse…”
Get full text

Micronutrients for Chronic Heart Failure: End of the Road or Path to Enlightenment? by Witte, Klaus K.A., Byrom, Rowenna

Get full text

Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction by Gierula, John, Cubbon, Richard M, Jamil, Haqeel A, Byrom, Rowenna, Baxter, Paul D, Pavitt, Sue, Gilthorpe, Mark S, Hewison, Jenny, Kearney, Mark T, Witte, Klaus K A

“…Heart failure and left ventricular (LV) systolic dysfunction (LVSD) are common in patients with permanent pacemakers. The aim was to determine if cardiac…”
Get full text

The effect of altering heart rate on ventricular function in patients with heart failure treated with β-blockers by Thackray, Simon D.R., Ghosh, Justin M., Wright, Graham A., Witte, Klaus K.A., Nikitin, Nikolay P., Kaye, Gerald C., Clark, Andrew L., Tweddel, Ann, Cleland, John G.F.

“…β-Blockers are effective for the treatment of heart failure, but their mechanism of action is unresolved. Heart rate reduction may be a central mechanism or a…”
Get full text

Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction by Gierula, John, Cubbon, Richard M, Jamil, Haqeel A, Byrom, Rowenna J, Waldron, Zac L, Pavitt, Sue, Kearney, Mark T, Witte, Klaus K.A

“…INTRODUCTIONPatients with right ventricular pacemakers are at increased risk of left ventricular systolic dysfunction (LVSD). We aimed to establish the…”
Get full text

The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population by Thackray, Simon D.R., Witte, Klaus K.A., Nikitin, Nikolay P., Clark, Andrew L., Kaye, Gerald C., Cleland, John G.F.

“…Aims To assess the prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in the chronically paced population. Methods and Results…”
Get full text

Cardiac resynchronisation therapy for chronic heart failure by CUBBON, Richard M, WITTE, Klaus K. A

“…Chronic heart failure is common, affecting about 900,000 people in the UK and with a prevalence of about 6-10% in people aged over 65 years; despite modern…”
Get full text

Dyspnoea versus fatigue: Additional prognostic information from symptoms in chronic heart failure? by Witte, Klaus K.A., Clark, Andrew L.

“…Background: In non-heart failure populations, dyspnoea reported by the patient as the reason for stopping an exercise test is associated with a worse prognosis…”
Get full text

Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function by Nikitin, Nikolay P, Witte, Klaus K.A, Clark, Andrew L, Cleland, John G.F

“…Long-axis function (systolic shortening and diastolic lengthening) is impaired in patients with symptoms of heart failure and preserved global left ventricular…”
Get full text

Letter by Begg et al regarding article, "The effects of vitamin d supplementation on physical function and quality of life in older heart failure patients: a randomized controlled trial" by Begg, Gordon A, Cleland, John G F, Witte, Klaus K A

Get full text